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, a primary stock of cryopreserved infected cells BIIC was prepared by infecting 25 mL of Sf9 cells at a concentration of 1×10 6 C/mL with 25 µL of untitered liquid P1PP1 baculovirus stock (an estimated MOI of approximately 3 pfu/cell). The cells were cryopreserved when the average diameter increases by 20-30% of their pre-infected diameter and the viability was above 95%. Sf9 cells were grown and infected at 28 °C and 150 rpm in complete TNM-FH medium [TNM-FH medium (Sigma-Aldrich), supplemented with 10% Fetal Bovine Serum (FBS) (BioWest), 0.5% antibiotic-antimycotic (Sigma-Aldrich), and 0.1% Pluronic-F68 (Invitrogen)]. The cells were cryopreserved at a density of 1×10 7 C/mL in liquid nitrogen and complete TNM-FH medium and 10% DMSO (Sigma-Aldrich). Cell density was determined by hemocytometer counts, and the cell viability was evaluated by Trypan Blue staining.
FUT8 expression and purification Sf9 cells were infected at a cell density of 1×10 6 C/mL. The baculovirus titer was estimated using insect cell density at time of infection and a conservative cellular baculovirus maximum production rate of 100 pfu/cell for 1×10 6 C/mL meaning 1×10 8 pfu/mL. BIIC stock was thawed in a 37 °C water bath and diluted 1:100 into cell-free medium, then 10 mL of infected cell-free medium was added to 1 L of uninfected cells (1:1000 dilution) 7 .
The medium was collected after 72 h of expression followed by purification. The purification of the secreted protein was accomplished by diluting the medium 1:1 with equilibration buffer (50 mM Tris-HCl, pH 7.5, 0.5 M NaCl) and loading to 2 mL of pre-equilibrated Ni-Sepharose Excell
S3
(GE Healthcare) 8 . The column was rinsed using 200 mL of wash buffer (50 mM Tris-HCl pH 7.5, 0.5 M NaCl, 50 mM imidazole), and finally eluted with 5 mL of elution buffer (50 mM TrisHCl pH 7.5, 0.5 M NaCl, 250 mM imidazole). The enzyme was desalted and concentrated using Amicon YM-30 ultrafiltration membrane (Millipore) against desalting buffer (50 mM Tris-HCl pH 7.5). Purified FUT8 was confirmed by SDS-PAGE (>90% pure) and western blot ( Figure  S1 ). Using TIPS method 0.42 mg of human FucT8 were purified from 1 L cultures as determined using Bradford method. The activity of recombinant FUT8 was confirmed by using N000 as a substrate, monitored by MS ( Figure S2) . Figure S1 . SDS-PAGE and western blot analysis of FUT8. 1) SDS-PAGE of medium after overexpression of FUT8; 2) SDS-PAGE of purified FUT8; and 3) western blot analysis of purified FUT8 using anti-His antibody as the primary antibody. BSA, a major protein component of Fetal Bovine Serum used in the culture medium, has similar molecular weight as that of FUT8. 
III. Substrate specificity study of FUT8
A detailed substrate specificity study of FUT8 was performed using 77 chemically or chemoenzymatically synthesized, or commercially available N-glycans (with free reducing end) as acceptors ( Figure S3 ). Reactions were performed in a 96 well PCR plate, with each well (20 L total volume) contains one N-glycan substrate (0.3 mM, 2.5 g to 15.1 g), GDP-Fuc (1 mM), FUT8 (0.05 mg/mL) and MES buffer (100 mM, pH 7.0). Reactions were incubated at 37 °C for 4 h in an Eppendorf thermocycler (Mastercycler Pro), followed by enzyme inactivation at 95 °C for 20 min. A negative control was also set up using N000 as substrate without enzyme. After centrifugation (13,000 g for 10 min), the supernatant was analyzed by HPLC using an analytical Waters XBridge BEH amide column (130 Å, 5 m, 4.6 x 250 mm), detected by an evaporative light scattering detector (Shimadzu ELSD-LTII). Gradient elution (%B: 75-60% for glycans with less than 9 monosaccharides, 70-55% for glycans with 9 or more monosaccharides) was performed with Solvent A (100 mM ammonium formate, pH 3.4) and Solvent B (Acetonitrile). The percent yields (average of three replicated reactions, see Table S1 ) were calculated as % = Product peak area/ (Product peak area + Substrate peak area) × 100. Figure S3 . The 77 N-glycans used as acceptor for FUT8 substrate specificity study. The preparation and characterization of all substrates were published previously 9 . The ones in the red square were found to be suitable acceptors for FUT8.
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IV. General methods for glycan synthesis and purification
Reactions catalyzed by B4GALT1, Hp1,3FT, PmST1m and Pd2,6ST were performed and monitored as we described previously 9 . Reactions catalyzed by FUT8 were performed in 100 mM MES buffer (pH 7.0), containing 2 mM glycan acceptor, 4 mM GDP-Fuc donor, FastAP (10 U/mL) and 0.1 mg/mL FUT8. Reactions were allowed to proceed for 6 h to overnight at 37 °C until substrates were totally converted to products (monitored by HPLC-ELSD as described above). The reactions were then quenched by freezing in -80 °C for 30 min, followed with concentration by lyophilization. HPLC-A 210nm was then used to purify target glycans using a semi-preparative amide column (130 Å, 5 m, 10 mm × 250 mm). The running conditions are solvent A: 100 mM ammonium formate (for glycans with Neu5Ac residues) or water (for glycans without Neu5Ac residues), pH 3.4; solvent B: acetonitrile; flow rate: 4 mL/min; B%: 70-55% within 25 min. Products containing portions were then concentrated and lyophilized for characterization. The purity of each glycan was confirmed by HPLC-ELSD using an analytical Waters amide column (130 Å, 5 m, 4.6 mm × 250 mm). The running conditions are solvent A: 100 mM ammonium formate, pH 3.4; solvent B: acetonitrile; flow rate: 1 mL/min; B%: 65-50% within 25 min. 
